Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise vaccines for NDV (Newcastle disease), either alone or in combination with our other proprietary vaccines.

At Gamma Vaccines we aim to develop innovative vaccines to prevent viral infections, ensuring a healthier future for all
MISSION
Gamma Vaccines is an early stage company developing innovative technology to produce broad spectrum vaccines against a variety of human and animal viruses, aimed at reducing the incidence of viral diseases and pandemic outbreaks.
About UsTechnology
Our vaccines are based on proprietary technologies initially developed in conjunction with leading Australian universities and offer new ways to induce broad spectrum immune responses against important viral pathogens.
Events
News
Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise vaccines for NDV (Newcastle disease), either alone or in combination with our other proprietary vaccines.
Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to investigate and develop vaccines that marry Gamma Vaccines manufacturing technology with Capricorn’s novel vaccines and Aptum’s innovative approach to increasing vaccine effectiveness.